ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

ACS names new officers.

December 5, 2003

NCI CTEP Approved Trials For the Month of August

August 30, 2013

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985